IN8BIO INC
INAB·45674E208·US·Common Stock·Healthcare - Biotechnology-Activist
INAB (IN8BIO INC) is held by 11 institutional investors as of Q1 2026. Largest holders: Alyeska Investment Group, L.P. ($1.4M), FRANKLIN RESOURCES INC ($1.4M), GEODE CAPITAL MANAGEMENT, LLC ($127,635). Net institutional sentiment: Bearish.
11
Holders
Avg rating(2 Elite)
$3M
Total Value
27% (15)
Fund Consensus
3 buying - 8 selling
Who's Trading
ActivistEFEMILY FAIRBAIRN2.2%May 29, 2026
ActivistLLLYTTON LAURENCE W10.0%Mar 2, 2026
ActivistEFEMILY FAIRBAIRN7.5%Jan 2, 2026
Activist68683 Capital Management, LLC7.9%Dec 30, 2025
ActivistBIBIOS Fund II, LP0.2%Dec 29, 2025
ActivistSTStonepine Capital Management, LLC9.9%Dec 22, 2025
ActivistWTWilliam Tai-Wei Ho3.7%Aug 13, 2025
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer